CAR T cell attack on cancer cells

In our latest issue...

Our September 2023 issue includes company profiles and editorial features focusing on oncology including immuno-oncology and antibodies. We also explore the highest-value M&As of 2023 so far.

Advertisement

Advertisement

Nature Careers

Jobs

Advertisement